Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he and Daniel Added co-authored published in JACC Journals, adding:
“In this editorial published in JACC Asia, Daniel Added and I comment on the results of the study by Puri et al., which evaluated attainment of LDL-C goals in Indian patients.
Unfortunately as seen in other countries most patients remained with still high LDL-C values despite the use of statin therapy in most of them.
Nowadays, it has been shown that more intensive cholesterol lowering to values around 30-40 mg/dL further reduces cardiovascular events in comparison with values around 90 mg/dL.
There is a need for access to additional cholesterol-lowering medications, such as ezetimibe, bempedoic acid, and PCSK9 inhibitors like evolocumab, alirocumab, and inclisiran to adequately control LDL-C and reduce the burden of ASCVD events.
Hopefully, the arrival of oral PCSK9 inhibitors like enlicited and laroprovastat will increase access to these therapies.”
Title: LDL-C Remains Elevated in Patients With Very High Cardiovascular Risk in India and Elsewhere
Authors: Daniel A. Added, Raul D. Santos

Title: Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide Study
Authors: Raman Puri, Manish Bansal, Kunal Mahajan, Rajeev Gupta, Vimal Mehta, Shamanna S. Iyengar, Dorairaj Prabhakar, Rajeev Agarwala, Aziz Khan, Neil Bordoloi, Nagaraj Desai, Sheeba George, Biswajit Majumder, Smit Shrivastava, Vinod Vijan, Asha Mahilmaran, Dharmendra Jain, Sadanand R. Shetty, P. Barton Duell, Nathan D. Wong

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health